e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
458.81
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
433
Open
458.81
Bid (Size)
459.02 (40)
Ask (Size)
471.29 (40)
Prev. Close
458.81
Today's Range
458.81 - 458.81
52wk Range
362.50 - 519.68
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Market-Beating Stocks Worth Investigating
February 04, 2026
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...
Via
StockStory
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Presents a Compelling Growth and Breakout Opportunity
↗
February 02, 2026
Via
Chartmill
Performance
YTD
+1.5%
+1.5%
1 Month
-2.0%
-2.0%
3 Month
+10.2%
+10.2%
6 Month
+22.1%
+22.1%
1 Year
-6.1%
-6.1%
More News
Read More
Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals
↗
January 29, 2026
Via
The Motley Fool
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case
↗
January 29, 2026
Via
Chartmill
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
January 28, 2026
Via
StockStory
Topics
Stocks
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment Candidate
↗
January 13, 2026
Via
Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Compelling Value Stock Candidate
↗
January 01, 2026
Via
Chartmill
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
January 23, 2026
From
Equity Insider
Via
GlobeNewswire
Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)
January 21, 2026
Via
StockStory
Topics
Artificial Intelligence
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
January 20, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
January 19, 2026
Via
StockStory
Topics
Artificial Intelligence
My Forever Portfolio: 5 Stocks I Don't Plan on Ever Selling
↗
January 19, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
3 Profitable Stocks with Open Questions
January 15, 2026
Via
StockStory
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
↗
January 14, 2026
Via
The Motley Fool
Travere Therapeutics Shares Fall After FDA Extends Filspari Review for FSGS
January 13, 2026
Via
MarketMinute
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
January 11, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
The Best Stocks to Invest $50,000 in Right Now
↗
January 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge
January 09, 2026
Via
MarketMinute
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
↗
January 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Moderna’s Second Act: Analyzing the 2026 Pipeline Pivot and Recent Stock Surge
January 07, 2026
Via
PredictStreet
Topics
Economy
Initial Public Offering
Intellectual Property
Stocks making big moves yesterday: Herbalife, Vertex Pharmaceuticals, Micron, Amkor, and Palantir Technologies
January 07, 2026
Via
StockStory
Topics
Artificial Intelligence
Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why
January 06, 2026
Via
StockStory
My 10 Top Stocks to Buy to Start the New Year Off Right
↗
January 05, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
BofA Unveils Q1 2026 Top Stock Picks: High-Conviction Bets on AI Infrastructure and Health Care Valuations
January 02, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Best Stocks to Invest $1,000 in to Start the New Year Off Right
↗
January 01, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 458.81
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 02/05/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 119.03B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 119B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.